Fastgene detects any pathogenic agent in a drop of blood or saliva.
Public health crises, now no longer just plot points of Hollywood thrillers, are prompting the need to establish detection methods that can quickly and reliably diagnose these threats. French start-up Elvesys recently introduced what it claimed is the world's fastest pathogen detection platform to inexpensively diagnose patients.
Fastgene detects any pathogenic agent in a drop of blood or saliva. Using Fastgene, healthcare workers can detect Ebola in six minutes and anthrax in seven minutes, which is respectively 7 and 14 times faster than the world’s best current technologies, according to the company. The Fastgene diagnostic system is based on the quantitative polymerase chain reaction (qPCR), a molecular test that detect bacterial and viruses DNA. It uses a patented microfluidic thermalisation technique using both the relevant advantages of microfluidic chips and Elveflow high performance pressure controllers.
Elvesys's work is powered by National Instruments' USB-6003 multifunction DAQ device and LabVIEW software.